{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:05:49Z","timestamp":1793379949369,"version":"4.5.0"},"reference-count":351,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY450"],"award-info":[{"award-number":["2024KY450"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004147","name":"Tsinghua University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115337","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:08:03Z","timestamp":1789085283000},"page":"115337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PA","title":["mRNA vaccines for glioblastoma: integrating multiomics and nanomedicine to overcome spatiotemporal heterogeneity"],"prefix":"10.1016","volume":"399","author":[{"given":"Shaoxing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhe","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenning","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen S.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115337_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpneuro0289","article-title":"Epidemiology and molecular pathology of glioma","volume":"2","author":"Schwartzbaum","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41467-023-36005-1","article-title":"Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0015","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"van den Bent","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115337_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2026.115337_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.115337_bb0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/aogs.14005","article-title":"Investigation of malignant cells in ovarian tissue from a patient with central nervous system primitive neuroectodermal tumor relapse after ovarian tissue transplantation","volume":"100","author":"Nguyen","year":"2021","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jconrel.2026.115337_bb0040","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0045","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1038\/s41467-020-17139-y","article-title":"Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities","volume":"11","author":"Oh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115337_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tranon.2019.09.002","article-title":"Development of a microfluidic culture paradigm for ex vivo maintenance of human glioblastoma tissue: a new glioblastoma model?","volume":"13","author":"Olubajo","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neucir.2020.12.004","article-title":"A rare central nervous system tumor of childhood with spongiform appearance on brain magnetic resonance imaging; primary diffuse leptomeningeal oligodendrogliomatosis","volume":"33","author":"Tekin","year":"2021","journal-title":"Neurocirugia (Astur\u202f: Engl. Ed.)"},{"key":"10.1016\/j.jconrel.2026.115337_bb0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/2326-6066.CIR-22-0655","article-title":"Driver mutations dictate the immunologic landscape and response to checkpoint immunotherapy of glioblastoma","volume":"11","author":"Yeo","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102279","article-title":"Drivers of heterogeneity in the glioblastoma immune microenvironment","volume":"85","author":"Brosque","year":"2023","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/neuonc\/noag018","article-title":"Distinct tumor immune microenvironmental (TIME) landscapes drive divergent immunotherapy responses in glioblastoma","volume":"28","author":"Weng","year":"2026","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0080","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","article-title":"Integrative spatial analysis reveals a multi-layered organization of glioblastoma","volume":"187","author":"Greenwald","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115337_bb0085","doi-asserted-by":"crossref","first-page":"1356611","DOI":"10.3389\/fgene.2024.1356611","article-title":"Cellular diversity through space and time: adding new dimensions to GBM therapeutic development","volume":"15","author":"Johnson","year":"2024","journal-title":"Front. Genet."},{"key":"10.1016\/j.jconrel.2026.115337_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189383","article-title":"Spatial heterogeneity in glioblastoma: decoding the role of perfusion","volume":"1880","author":"Saha","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb0095","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","article-title":"Modern methods for delivery of drugs across the blood-brain barrier","volume":"64","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb0100","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1021\/nn402662d","article-title":"Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier","volume":"7","author":"Miura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115337_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40478-023-01569-y","article-title":"Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators","volume":"11","author":"Segura-Collar","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115337_bb0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115337_bb0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trecan.2015.10.009","article-title":"Glioblastoma: defining tumor niches","volume":"1","author":"Hambardzumyan","year":"2015","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115337_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/neuonc\/noac138","article-title":"Dysfunctional dendritic cells limit antigen-specific T cell response in glioma","volume":"25","author":"Friedrich","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb0145","doi-asserted-by":"crossref","first-page":"91779","DOI":"10.18632\/oncotarget.21586","article-title":"Recurrent glioma clinical trial, CheckMate-143: the game is not over yet","volume":"8","author":"Filley","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2026.115337_bb0150","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","article-title":"Brain tumor microenvironment and host state: implications for immunotherapy","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-020-03448-1","article-title":"A review of glioblastoma immunotherapy","volume":"151","author":"Medikonda","year":"2021","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-021-00574-0","article-title":"Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics","volume":"23","author":"Twomey","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115337_bb0165","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1200\/jco.2015.33.15_suppl.3010","article-title":"Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143","volume":"33","author":"Sampson","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/neuonc\/nox208","article-title":"Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143","volume":"20","author":"Omuro","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0175","first-page":"4","article-title":"Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: results from exploratory phase I cohorts of CheckMate 143","author":"Omuro","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.jconrel.2026.115337_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","article-title":"Actively personalized vaccination trial for newly diagnosed glioblastoma","volume":"565","author":"Hilf","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115337_bb0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115337_bb0190","first-page":"14","article-title":"Next-generation mRNA vaccines in melanoma: advances in delivery and combination strategies","author":"Zoroddu","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115337_bb0195","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-025-09655-y","article-title":"SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade","volume":"647","author":"Grippin","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115337_bb0200","first-page":"13","article-title":"Engineering universal cancer immunity: non-tumor-specific mRNA vaccines trigger epitope spreading in cold tumors","author":"Magoola","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115337_bb0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-025-01124-x","article-title":"Ionizable lipid nanoparticles of mRNA vaccines elicit NF-kappaB and IRF responses through toll-like receptor 4","volume":"10","author":"Zelkoski","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.115337_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105543","article-title":"Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1\/PD-L1 blocking therapy and long-term immunity in a cold tumour model","volume":"112","author":"Fournier","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jconrel.2026.115337_bb0215","doi-asserted-by":"crossref","first-page":"2543599","DOI":"10.1080\/21645515.2025.2543599","article-title":"Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity","volume":"21","author":"Mendez-Gomez","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2026.115337_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13073-024-01281-z","article-title":"mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors","volume":"16","author":"Trivedi","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.jconrel.2026.115337_bb0225","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.cell.2024.04.003","article-title":"RNA aggregates harness the danger response for potent cancer immunotherapy","volume":"187","author":"Mendez-Gomez","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115337_bb0230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41571-024-00902-1","article-title":"Cancer mRNA vaccines: clinical advances and future opportunities","volume":"21","author":"Sayour","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0235","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12951-024-02882-x","article-title":"Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials","volume":"22","author":"Karimi-Sani","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0240","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/ar200019c","article-title":"Theranostic nanomedicine","volume":"44","author":"Lammers","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ccell.2025.11.006","article-title":"Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence","volume":"44","author":"Piyadasa","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115337_bb0250","doi-asserted-by":"crossref","first-page":"1507632","DOI":"10.3389\/fonc.2025.1507632","article-title":"Integrative multi-omic profiling of the neoantigen landscape of glioblastoma for the development of therapeutic vaccines reveals vast heterogeneity in immunogenic signatures","volume":"15","author":"Lin","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0730","article-title":"Lipid nanoparticles for mRNA delivery in brain via systemic administration","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115337_bb0260","doi-asserted-by":"crossref","first-page":"eadv8761","DOI":"10.1126\/scitranslmed.adv8761","article-title":"Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing post-operative spatiotemporal blood-brain barrier disruption","volume":"18","author":"Fernandes","year":"2026","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jconrel.2026.115337_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189480","article-title":"Nanoparticulate delivery and targeting of RNA to the brain","volume":"1880","author":"Gupta","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb0270","first-page":"12","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0275","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41587-022-01525-6","article-title":"An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts","volume":"41","author":"Dousis","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0280","first-page":"11","article-title":"In vitro transcribed RNA-based platform vaccines: past, present, and future","author":"Perenkov","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115337_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104772","article-title":"The promise of mRNA vaccines in cancer treatment: technology, innovations, applications, and future directions","volume":"212","author":"Tang","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.70041","article-title":"mRNA Cancer vaccines: from pandemic paradigm to personalized oncology therapeutics","volume":"4","author":"Yang","year":"2025","journal-title":"Cancer Innov."},{"key":"10.1016\/j.jconrel.2026.115337_bb0295","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1039\/D5SC07482G","article-title":"Time-ordered-expression mRNA (TOE mRNA) for melanoma RNA vaccines","volume":"17","author":"Zhang","year":"2026","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2026.115337_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.672508","article-title":"Making a cold tumor hot: the role of vaccines in the treatment of glioblastoma","volume":"11","author":"Frederico","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0305","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2019.09.006","article-title":"Combination immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors","volume":"36","author":"Grosser","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115337_bb0310","doi-asserted-by":"crossref","first-page":"44407","DOI":"10.1021\/acsami.0c08473","article-title":"Nanoparticle delivery of MnO(2) and antiangiogenic therapy to overcome hypoxia-driven tumor escape and suppress hepatocellular carcinoma","volume":"12","author":"Chang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115337_bb0315","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115337_bb0320","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/2326-6066.CIR-18-0599","article-title":"Reduced neoantigen expression revealed by longitudinal multiomics as a possible immune evasion mechanism in glioma","volume":"7","author":"Nejo","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00262-025-04178-x","article-title":"Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma","volume":"74","author":"Lutz","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.115337_bb0330","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115337_bb0335","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","article-title":"Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial","volume":"9","author":"Liau","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40364-024-00644-3","article-title":"mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends","volume":"12","author":"Gao","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115337_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030728","article-title":"Development of RNA\/DNA hydrogel targeting toll-like receptor 7\/8 for sustained RNA release and potent immune activation","volume":"25","author":"Komura","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115337_bb0355","article-title":"Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes","volume":"121","author":"Zhang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115337_bb0360","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1158\/1538-7445.AM2025-6622","article-title":"Abstract 6622: dissecting in situ states of invading glioblastoma cells using single-cell and spatial transcriptomics","volume":"85","author":"Hara","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0365","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1038\/s41467-025-61780-4","article-title":"The tumor-sentinel lymph node immuno-migratome reveals CCR7(+) dendritic cells drive response to sequenced immunoradiotherapy","volume":"16","author":"Saddawi-Konefka","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0370","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.trecan.2025.04.008","article-title":"Tumor-draining lymph nodes - friend or foe during immune checkpoint therapy?","volume":"11","author":"von Renesse","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb0375","article-title":"Insights into the mechanisms of immune-checkpoint inhibitors gained from spatiotemporal dynamics of the tumor microenvironment","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.115337_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2026.189544","article-title":"Immunotherapy-driven remodeling of the tumor immune microenvironment: spatiotemporal heterogeneity and multidimensional dynamics","volume":"1881","author":"Pan","year":"2026","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb0385","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev-immunol-102319-103410","article-title":"Meningeal immunity and its function in maintenance of the central nervous system in health and disease","volume":"38","author":"Alves de Lima","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0390","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf7844","article-title":"Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma","volume":"373","author":"Cugurra","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115337_bb0395","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ni.3423","article-title":"Origin, fate and dynamics of macrophages at central nervous system interfaces","volume":"17","author":"Goldmann","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0400","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri1130","article-title":"Three or more routes for leukocyte migration into the central nervous system","volume":"3","author":"Ransohoff","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0405","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.immuni.2008.12.013","article-title":"Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesis-associated system of reticular fibers","volume":"30","author":"Wilson","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115337_bb0410","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","article-title":"T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma","volume":"24","author":"Woroniecka","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0415","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1200\/JCO.2017.72.8089","article-title":"Immunotherapy for brain tumors","volume":"35","author":"Sampson","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0420","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-021-00507-y","article-title":"Intratumoural administration and tumour tissue targeting of cancer immunotherapies","volume":"18","author":"Melero","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0425","first-page":"13","article-title":"Focused ultrasound combined with microbubbles in central nervous system applications","author":"Chen","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0430","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41422-020-0287-8","article-title":"Meningeal lymphatic vessels regulate brain tumor drainage and immunity","volume":"30","author":"Hu","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0435","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.it.2025.12.007","article-title":"Decoding brain border immunity to enable future therapeutic avenues","volume":"47","author":"Van Hoecke","year":"2026","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0440","first-page":"vdaf135","article-title":"Advancing vaccine-based immunotherapy in glioblastoma treatment","volume":"7","author":"Singh","year":"2025","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.jconrel.2026.115337_bb0445","doi-asserted-by":"crossref","first-page":"1259562","DOI":"10.3389\/fimmu.2023.1259562","article-title":"Dendritic cell vaccine of gliomas: challenges from bench to bed","volume":"14","author":"Zheng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0450","doi-asserted-by":"crossref","first-page":"2556591","DOI":"10.1080\/21645515.2025.2556591","article-title":"Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival","volume":"21","author":"Bota","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2026.115337_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217928","article-title":"Neuroimmunology-driven CAR T-cell therapeutics for gliomas: translational challenges and clinical trial paradigm innovation","volume":"631","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.115337_bb0460","first-page":"13","article-title":"Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directions","author":"Walton","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb0465","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0470","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noae165.0362","article-title":"Tumor responses in a randomized phase IIB trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas","volume":"26","author":"Merrell","year":"2024","journal-title":"Neuro-Oncology."},{"key":"10.1016\/j.jconrel.2026.115337_bb0475","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s11864-024-01211-6","article-title":"An update on the clinical status, challenges, and future directions of oncolytic virotherapy for malignant gliomas","volume":"25","author":"Stergiopoulos","year":"2024","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0480","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.36.15_suppl.2017","article-title":"VXM01 phase I study in patients with progressive glioblastoma: final results","volume":"36","author":"Wick","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0485","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115337_bb0490","first-page":"12","article-title":"697 Preliminary immunogenicity results from the dose escalation phase of a first-in-human study of the mRNA-based cancer vaccine CVGBM in patients with newly diagnosed MGMT-unmethylated glioblastoma","author":"de Freitas Chama","year":"2024","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb0495","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115337_bb0500","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115337_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244148","article-title":"Immune checkpoint inhibitors in glioblastoma IDHwt treatment: a systematic review","volume":"16","author":"Baskaran","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115337_bb0510","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10143-025-04043-6","article-title":"Efficacy and safety of immune checkpoint inhibitors and mTOR inhibitors as targeted therapy for glioblastoma: a systematic review and meta-analysis of randomized clinical trials","volume":"49","author":"Gomez","year":"2026","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb0515","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0520","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/noac099","article-title":"Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: an international randomized phase III trial","volume":"25","author":"Omuro","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0525","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/neuonc\/noac116","article-title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter","volume":"24","author":"Lim","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0530","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1078-0432.CCR-16-2057","article-title":"Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination","volume":"23","author":"Batich","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0535","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13Ralpha2 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115337_bb0540","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.2024.42.16_suppl.2062","article-title":"Safety and efficacy of B7-H3 targeting CAR-T cell therapy for patients with recurrent GBM","volume":"42","author":"Zhang","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.851877","article-title":"Safety and efficacy of chimeric antigen receptor T-cell therapy for glioblastoma: a systemic review and meta-analysis","volume":"12","author":"Jang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0550","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/1744666X.2025.2494656","article-title":"The therapeutic effect of mRNA vaccines in glioma: a comprehensive review","volume":"21","author":"Afrashteh","year":"2025","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104459","article-title":"Current mRNA-based vaccine strategies for glioma treatment","volume":"202","author":"Mao","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0560","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115337_bb0565","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01775-23","article-title":"Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses","volume":"15","author":"Wan","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.jconrel.2026.115337_bb0570","first-page":"17","article-title":"Implications of anaphylaxis following mRNA-LNP vaccines: it is urgent to eliminate PEG and find alternatives","author":"Song","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0575","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.115337_bb0580","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS2100","article-title":"Randomized phase IIb trial of a CMV vaccine immunotherapeutic candidate (VBI-1901) in recurrent glioblastomas","volume":"42","author":"Merrell","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0585","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s40259-022-00553-7","article-title":"Teserpaturev\/G47Delta: first approval","volume":"36","author":"Frampton","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2026.115337_bb0590","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12026-014-8505-4","article-title":"Tumor antigen discovery through translation of the cancer genome","volume":"58","author":"Khodadoust","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0595","first-page":"7","article-title":"Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death","author":"Hieronymus","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2026.115337_bb0600","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jconrel.2026.115337_bb0605","doi-asserted-by":"crossref","first-page":"9775","DOI":"10.7150\/thno.61677","article-title":"Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0610","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40537-022-00643-x","article-title":"Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development","volume":"9","author":"Wu","year":"2022","journal-title":"J. Big Data"},{"key":"10.1016\/j.jconrel.2026.115337_bb0615","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41467-021-27667-w","article-title":"Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity","volume":"13","author":"Lam","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0620","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ccell.2023.12.015","article-title":"Integrated proteogenomic characterization of glioblastoma evolution","volume":"42","author":"Kim","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.115337_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.701065","article-title":"Identification of tumor antigens and immune landscape in glioblastoma for mRNA vaccine development","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.jconrel.2026.115337_bb0630","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41016-022-00301-4","article-title":"Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development","volume":"8","author":"Wang","year":"2022","journal-title":"Chin. Neurosurg. J."},{"key":"10.1016\/j.jconrel.2026.115337_bb0635","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/neuonc\/noaf113","article-title":"Charting the single-cell and spatial landscape of IDH-wild-type glioblastoma with GBmap","volume":"27","author":"Ruiz-Moreno","year":"2025","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0640","doi-asserted-by":"crossref","first-page":"eadn4306","DOI":"10.1126\/sciadv.adn4306","article-title":"Single-cell multi-omics sequencing uncovers region-specific plasticity of glioblastoma for complementary therapeutic targeting","volume":"10","author":"Wang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115337_bb0645","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-025-02106-9","article-title":"Genomic heterogeneity drives distinct infiltration patterns in glioblastoma","volume":"14","author":"Harwood","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0650","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41467-023-36707-6","article-title":"Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas","volume":"14","author":"Ren","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0655","first-page":"1534","article-title":"A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets","volume":"3","author":"Wang","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115337_bb0660","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","article-title":"T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10","volume":"13","author":"Ravi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0665","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41467-023-38186-1","article-title":"Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states","volume":"14","author":"Al-Dalahmah","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0670","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1038\/s41467-024-47185-9","article-title":"Microenvironmental reorganization in brain tumors following radiotherapy and recurrence revealed by hyperplexed immunofluorescence imaging","volume":"15","author":"Watson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0675","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.annonc.2022.11.008","article-title":"Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy","volume":"34","author":"White","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0680","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1158\/1078-0432.CCR-23-3077","article-title":"Integrating multisector molecular characterization into personalized peptide vaccine design for patients with newly diagnosed glioblastoma","volume":"30","author":"Johanns","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0685","doi-asserted-by":"crossref","first-page":"1727642","DOI":"10.3389\/fimmu.2025.1727642","article-title":"OmniNeo: a multi-omics pipeline incorporating proteomics and AI selection for neoantigen optimization in tumor immunotherapy","volume":"16","author":"Lu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0690","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746168","article-title":"Surfaceome proteomic of glioblastoma revealed potential targets for immunotherapy","volume":"12","author":"Rose","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0695","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1093\/bioinformatics\/btab479","article-title":"MHCVision: estimation of global and local false discovery rate for MHC class I peptide binding prediction","volume":"37","author":"Pearngam","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0700","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2014-04-567933","article-title":"Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia","volume":"124","author":"Rajasagi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115337_bb0705","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1479-5876-5-18","article-title":"Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70","volume":"5","author":"Zobywalski","year":"2007","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115337_bb0710","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics \u2013 developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115337_bb0715","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313677121","article-title":"Structure of saguaro cactus virus 3\u2032 translational enhancer mimics 5\u2032 cap for eIF4E binding","volume":"121","author":"Ojha","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.115337_bb0720","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1038\/s41467-018-05482-0","article-title":"Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies","volume":"9","author":"Pardi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0725","article-title":"Updated considerations for the immunopharmacological aspects of the \u201ctalented mRNA vaccines\u201d","volume":"11","author":"Perrotta","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115337_bb0730","first-page":"10","article-title":"The molecular basis of coupling between poly(A)-tail length and translational efficiency","author":"Xiang","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2026.115337_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102405","article-title":"The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines","volume":"107","author":"Wei","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","article-title":"Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency","volume":"18","author":"Kim","year":"2022","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0745","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrm.2017.103","article-title":"Functional 5\u2019 UTR mRNA structures in eukaryotic translation regulation and how to find them","volume":"19","author":"Leppek","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0750","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.apsb.2023.11.003","article-title":"A novel deep generative model for mRNA vaccine development: designing 5\u2019 UTRs with N1-methyl-pseudouridine modification","volume":"14","author":"Tang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115337_bb0755","doi-asserted-by":"crossref","first-page":"lqae028","DOI":"10.1093\/nargab\/lqae028","article-title":"mRNAid, an open-source platform for therapeutic mRNA design and optimization strategies","volume":"6","author":"Vostrosablin","year":"2024","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.jconrel.2026.115337_bb0760","doi-asserted-by":"crossref","first-page":"vbaf134","DOI":"10.1093\/bioadv\/vbaf134","article-title":"UTRGAN: learning to generate 5\u2019 UTR sequences for optimized translation efficiency and gene expression","volume":"5","author":"Barazandeh","year":"2025","journal-title":"Bioinform. Adv."},{"key":"10.1016\/j.jconrel.2026.115337_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113544","article-title":"Enhancing mRNA translation efficiency with discriminative and generative artificial intelligence by optimizing 5\u2032 UTR sequences","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2026.115337_bb0770","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12864-025-11269-7","article-title":"UTR-insight: integrating deep learning for efficient 5\u2019 UTR discovery and design","volume":"26","author":"Pan","year":"2025","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0775","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrm.2017.91","article-title":"Codon optimality, bias and usage in translation and mRNA decay","volume":"19","author":"Hanson","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040180","article-title":"High guanine and cytosine content increases mRNA levels in mammalian cells","volume":"4","author":"Kudla","year":"2006","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0785","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115337_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107534","article-title":"The challenge and prospect of mRNA therapeutics landscape","volume":"40","author":"Weng","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2026.115337_bb0795","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1016\/j.ymthe.2025.09.011","article-title":"Immunology of RNA-based vaccines: the critical interplay between inflammation and expression","volume":"33","author":"Tregoning","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115337_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113900","article-title":"Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across","volume":"176","author":"Minnaert","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb0805","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.7150\/thno.127558","article-title":"A ribonucleotide carbohydrate system (iRNC) enhances antigen presentation and controls glioblastoma","volume":"16","author":"Kim","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0810","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noae165.0341","article-title":"First in human study of the mRNA-based cancer vaccine CVGBM in patients with newly-diagnosed and surgically resected MGMT-unmethylated glioblastoma: first results from the dose escalation phase","volume":"26","author":"Tabatabai","year":"2024","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131427","article-title":"Review: N1-methyl-pseudouridine (m1\u03a8): friend or foe of cancer?","volume":"267","author":"Rubio-Casillas","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0820","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ymthe.2021.01.029","article-title":"Corticosteroids and mRNA vaccines: a word of caution","volume":"29","author":"Zhong","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115337_bb0825","doi-asserted-by":"crossref","first-page":"1758004","DOI":"10.1080\/2162402X.2020.1758004","article-title":"Dexamethasone premedication suppresses vaccine-induced immune responses against cancer","volume":"9","author":"Vormehr","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2026.115337_bb0830","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00262-013-1405-y","article-title":"BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide","volume":"62","author":"Sanchez-Perez","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.115337_bb0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059082","article-title":"Myeloablative temozolomide enhances CD8(+) T-cell responses to vaccine and is required for efficacy against brain tumors in mice","volume":"8","author":"Sanchez-Perez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115337_bb0840","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/2326-6066.CIR-14-0100","article-title":"Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide","volume":"3","author":"Mitchell","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0845","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115337_bb0850","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0855","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1016\/j.ymthe.2025.08.028","article-title":"Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity","volume":"33","author":"Lunavat","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115337_bb0860","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1021\/acsnano.4c05906","article-title":"pH-responsive polyethylene glycol engagers for enhanced brain delivery of PEGylated nanomedicine to treat glioblastoma","volume":"19","author":"Meng","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115337_bb0865","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: a systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0870","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1470-2045(23)00112-2","article-title":"Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial","volume":"24","author":"Sonabend","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0875","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","article-title":"Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","volume":"37","author":"Miao","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0880","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s12272-022-01418-x","article-title":"Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment","volume":"45","author":"Karim","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2026.115337_bb0890","first-page":"17","article-title":"Cracking the blood-brain barrier code: rational nanomaterial design for next-generation neurological therapies","author":"Najera-Maldonado","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0895","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2045-8118-9-23","article-title":"Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation","volume":"9","author":"Luissint","year":"2012","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2026.115337_bb0900","doi-asserted-by":"crossref","first-page":"2106860","DOI":"10.1002\/adfm.202106860","article-title":"Triculture model of in vitro BBB and its application to study BBB-associated chemosensitivity and drug delivery in glioblastoma","volume":"32","author":"Seo","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115337_bb0905","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1039\/D5BM01582K","article-title":"Translational roadmap of BBB-targeted nanoparticle strategies for neuroregenerative therapy in neurodegenerative diseases","volume":"14","author":"Lee","year":"2026","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115337_bb0910","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.irn.2016.06.001","article-title":"From the blood to the central nervous system: a nanoparticle\u2019s journey through the blood-brain barrier by transcytosis","volume":"130","author":"Fullstone","year":"2016","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0915","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199793","article-title":"Targeting transferrin receptor 1 for enhancing drug delivery through the blood-brain barrier for Alzheimer\u2019s disease","volume":"26","author":"Shen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115337_bb0920","doi-asserted-by":"crossref","first-page":"11990","DOI":"10.1038\/srep11990","article-title":"LRP-1-mediated intracellular antibody delivery to the central nervous system","volume":"5","author":"Tian","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115337_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.115107","article-title":"Single-ligand dual-targeting lipid nanoparticles for therapeutic mRNA delivery to glioblastoma across the blood-brain barrier","volume":"396","author":"Goo","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115337_bb0930","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41467-026-71646-y","article-title":"Co-delivering macrophage engager mRNA and PD-L1 antibody via tumor-responsive nanoparticles for glioblastoma immunotherapy","volume":"17","author":"Zhang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb0935","first-page":"12","article-title":"PLGA-PEG-ANG-2 nanoparticles for blood-brain barrier crossing: proof-of-concept study","author":"Hoyos-Ceballos","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0940","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241281321","article-title":"A novel ANG-BSA\/BCNU\/ICG MNPs integrated for targeting therapy of glioblastoma","volume":"23","author":"Liu","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.jconrel.2026.115337_bb0945","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2024.05.044","article-title":"To see or not to see: in vivo nanocarrier detection methods in the brain and their challenges","volume":"371","author":"Wehn","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115337_bb0950","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jpha.2020.05.002","article-title":"Current status of in vivo bioanalysis of nano drug delivery systems","volume":"10","author":"Wang","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jconrel.2026.115337_bb0955","doi-asserted-by":"crossref","first-page":"25910","DOI":"10.1039\/D5RA03578C","article-title":"Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery","volume":"15","author":"Senanayake","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2026.115337_bb0960","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.7150\/thno.25228","article-title":"Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles","volume":"8","author":"Johnsen","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115337_bb0965","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12987-025-00643-y","article-title":"The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo","volume":"22","author":"Bonvicini","year":"2025","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2026.115337_bb0970","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/anie.201411226","article-title":"A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery","volume":"54","author":"Wei","year":"2015","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115337_bb0975","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herve","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115337_bb0980","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/acs.molpharmaceut.2c00523","article-title":"Peptides as pharmacological carriers to the brain: promises, shortcomings and challenges","volume":"19","author":"Parrasia","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115337_bb0985","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","article-title":"Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies","volume":"23","author":"Mehdizadeh","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb0990","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12935-025-03731-z","article-title":"Harnessing exosomes for targeted drug delivery systems to combat brain cancer","volume":"25","author":"Basyoni","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2026.115337_bb0995","first-page":"3","article-title":"Acoustic emissions dose and spatial control of blood-brain barrier opening with focused ultrasound","author":"Woodworth","year":"2025","journal-title":"Device"},{"key":"10.1016\/j.jconrel.2026.115337_bb1000","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMoa2308719","article-title":"Ultrasound blood-brain barrier opening and aducanumab in Alzheimer\u2019s disease","volume":"390","author":"Rezai","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115337_bb1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114018","article-title":"Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma","volume":"385","author":"Shumer-Elbaz","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115337_bb1010","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb1015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16244235","article-title":"Innovative approaches to brain cancer: the use of magnetic resonance-guided focused ultrasound in glioma therapy","volume":"16","author":"Cwiklinska","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115337_bb1020","article-title":"Focused ultrasound for blood-brain barrier opening in brain tumor patients: technical nuances","volume":"8","author":"Del Bene","year":"2026","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.jconrel.2026.115337_bb1025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115337_bb1030","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41416-023-02393-w","article-title":"Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma","volume":"129","author":"Zhan","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119325","article-title":"Focused ultrasound mediated gene therapy for glioblastoma: a preclinical in vivo systematic review and meta-analysis","volume":"198","author":"ElNemer","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.115337_bb1040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2026.115337_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124582","article-title":"Biomedical applications of nanomaterials in the advancement of nucleic acid therapy: mechanistic challenges, delivery strategies, and therapeutic applications","volume":"241","author":"Yadav","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115190","article-title":"mRNA delivery systems for cancer immunotherapy: lipid nanoparticles and beyond","volume":"206","author":"Estape Senti","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1055","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1038\/s41467-024-54382-z","article-title":"gamma-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb1060","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/s41467-025-57598-9","article-title":"GCN5-targeted dual-modal probe across the blood-brain barrier for borders display in invasive glioblastoma","volume":"16","author":"Zheng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb1065","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1038\/s41467-025-59440-8","article-title":"Gene therapy with enterovirus 3 C protease: a promising strategy for various solid tumors","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb1070","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/acs.biochem.3c00371","article-title":"Lipid nanoparticles deliver mRNA to the brain after an intracerebral injection","volume":"62","author":"Tuma","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2026.115337_bb1075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mattod.2025.11.032","article-title":"Biodegradable lipid nanoparticles for genome editing in the brain via intrathecal administration","volume":"92","author":"Dong","year":"2026","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.115337_bb1080","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1021\/jacs.4c16898","article-title":"Convection-enhanced delivery of auristatin-conjugated layer-by-layer nanoparticles for glioblastoma treatment","volume":"147","author":"Pickering","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115337_bb1085","doi-asserted-by":"crossref","first-page":"17636","DOI":"10.1039\/D5NR00745C","article-title":"An optical\/magnetic imaging nanoplatform-mediated convection-enhanced delivery of oxaliplatin for glioma treatment","volume":"17","author":"He","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115337_bb1090","doi-asserted-by":"crossref","first-page":"1676691","DOI":"10.3389\/fonc.2025.1676691","article-title":"An implantable, intracerebral osmotic pump for convection-enhanced drug delivery in glioblastoma multiforme","volume":"15","author":"Berlet","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1095","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s00259-025-07527-1","article-title":"Convection-enhanced delivery of [(225)Ac]Ac-DOTA-SP in recurrent glioblastoma - tumour uptake","volume":"53","author":"Tulik","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2026.115337_bb1100","doi-asserted-by":"crossref","first-page":"17309","DOI":"10.1021\/acsnano.4c14573","article-title":"Glioblastoma cell derived exosomes as a potent vaccine platform targeting primary brain cancers and brain metastases","volume":"19","author":"Zou","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115337_bb1105","article-title":"Biomimetic hybrid vesicle nanoplatform with Pt-BaTiO3 for sonodynamic-immunotherapy of glioblastoma","volume":"522","author":"Li","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.115337_bb1110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.apsb.2023.07.025","article-title":"Advanced nano-based strategies for mRNA tumor vaccine","volume":"14","author":"Qu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115337_bb1115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115446","article-title":"Breaking the final barrier: evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome","volume":"214","author":"Mrksich","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1125","first-page":"14","article-title":"Comparison of physicochemical properties of LipoParticles as mRNA carrier prepared by automated microfluidic system and bulk method","author":"Ayad","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1130","first-page":"11","article-title":"Delivery strategies for mRNA vaccines","volume":"36","author":"Ramachandran","year":"2022","journal-title":"Pharmaceut. Med."},{"key":"10.1016\/j.jconrel.2026.115337_bb1135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2019.10.028","article-title":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening","volume":"316","author":"Guimaraes","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115337_bb1140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-021-01311-z","article-title":"mRNA vaccine: a potential therapeutic strategy","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb1145","first-page":"15","article-title":"Development of a library of disulfide bond-containing cationic lipids for mRNA delivery","author":"Shen","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1150","first-page":"14","article-title":"pH-responsive lipid nanoparticles achieve efficient mRNA transfection in brain capillary endothelial cells","author":"Sakurai","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114726","article-title":"From in vitro to in vivo: the dominant role of PEG-lipids in LNP performance","volume":"212","author":"Borah","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115337_bb1160","first-page":"17","article-title":"Formulation-driven optimization of PEG-lipid content in lipid nanoparticles for enhanced mRNA delivery in vitro and in vivo","author":"Liu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1165","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1039\/D2BM00168C","article-title":"In vivo delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression","volume":"10","author":"Algarni","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115337_bb1170","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/08982104.2024.2333755","article-title":"Design, synthesis, and in vitro gene transfer efficacy of novel ionizable cholesterol derivatives","volume":"34","author":"Wang","year":"2024","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb1175","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115337_bb1180","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202205354","article-title":"Brain-targeted HFn-cu-REGO Nanoplatform for site-specific delivery and manipulation of autophagy and cuproptosis in glioblastoma","volume":"19","author":"Jia","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115337_bb1185","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","article-title":"Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles","volume":"30","author":"Liu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115337_bb1190","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41565-025-01974-5","article-title":"Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape","volume":"20","author":"Omo-Lamai","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3897\/pharmacia.70.e98838","article-title":"Drug delivery to the brain \u2013 lipid nanoparticles-based approach","volume":"70","author":"Gugleva","year":"2023","journal-title":"PHARMACIA"},{"key":"10.1016\/j.jconrel.2026.115337_bb1200","first-page":"15","article-title":"Cationic polymers as transfection reagents for nucleic acid delivery","author":"Cai","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1205","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115337_bb1210","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1021\/ja4002376","article-title":"The effect and role of carbon atoms in poly(beta-amino ester)s for DNA binding and gene delivery","volume":"135","author":"Bishop","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115337_bb1215","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115337_bb1220","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2020.06.014","article-title":"Polymeric vehicles for nucleic acid delivery","volume":"156","author":"Piotrowski-Daspit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1225","doi-asserted-by":"crossref","first-page":"65339","DOI":"10.18632\/oncotarget.18689","article-title":"Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3\u2032-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression","volume":"8","author":"Bhowmik","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2026.115337_bb1230","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/adma.201204346","article-title":"Degradable terpolymers with alkyl side chains demonstrate enhanced gene delivery potency and nanoparticle stability","volume":"25","author":"Eltoukhy","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115337_bb1235","doi-asserted-by":"crossref","first-page":"13808","DOI":"10.1002\/anie.201608450","article-title":"Polymer-lipid nanoparticles for systemic delivery of mRNA to the lungs","volume":"55","author":"Kaczmarek","year":"2016","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2026.115337_bb1240","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1021\/acsomega.9b00489","article-title":"Codelivery of mRNA with alpha-galactosylceramide using a new lipopolyplex formulation induces a strong antitumor response upon intravenous administration","volume":"4","author":"Guevara","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2026.115337_bb1245","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/s41467-025-61299-8","article-title":"An mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite for cancer immunotherapy","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb1250","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/cmdc.201800186","article-title":"Modeling the accumulation of degradable polymer drug carriers in the brain","volume":"13","author":"Bolwerk","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2026.115337_bb1255","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s11671-025-04320-9","article-title":"Nano-antioxidants for neurodegenerative disorders: a scoping review","volume":"20","author":"Talaat","year":"2025","journal-title":"Discov. Nano"},{"key":"10.1016\/j.jconrel.2026.115337_bb1260","first-page":"14","article-title":"Non-viral delivery of RNA gene therapy to the central nervous system","author":"Hauck","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12943-025-02410-x","article-title":"PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy","volume":"24","author":"Kesharwani","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb1270","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113930","article-title":"Advances in mRNA non-viral delivery approaches","volume":"177","author":"Ibba","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1275","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14760584.2023.2232450","article-title":"Emergence of mRNA vaccines in the management of cancer","volume":"22","author":"Mohamad Razif","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2026.115337_bb1280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"Fotin-Mleczek","year":"2011","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2026.115337_bb1285","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.apsb.2022.11.013","article-title":"An mRNA vaccine elicits STING-dependent antitumor immune responses","volume":"13","author":"Chen","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115337_bb1290","first-page":"13","article-title":"Delivery of various cargos into cancer cells and tissues via cell-penetrating peptides: a review of the last decade","author":"Shoari","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1295","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1039\/D6OB00146G","article-title":"Cell-penetrating peptides for therapeutic applications: emerging design strategies and future directions","volume":"24","author":"Kim","year":"2026","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2026.115337_bb1300","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.addr.2004.10.010","article-title":"Cell-penetrating peptides: mechanism and kinetics of cargo delivery","volume":"57","author":"Zorko","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1305","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12951-021-00925-1","article-title":"Integrin alpha(2)beta(1)-targeting ferritin nanocarrier traverses the blood-brain barrier for effective glioma chemotherapy","volume":"19","author":"Huang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1310","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-022-00859-0","article-title":"Ferritin - a multifaceted protein scaffold for biotherapeutics","volume":"54","author":"Lee","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115337_bb1315","first-page":"29","article-title":"Bioactive molecules delivery through ferritin nanoparticles: sum up of current loading methods","author":"Lucignano","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115337_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126077","article-title":"Nano-biohybrids with cell-penetrating peptides: a molecular trojans for glioblastoma precision medicine","volume":"683","author":"Phatale","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115337_bb1325","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.actbio.2024.02.007","article-title":"Nanoparticle-mediated blockade of CXCL12\/CXCR4 signaling enhances glioblastoma immunotherapy: monitoring early responses with MRI radiomics","volume":"177","author":"Wei","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115337_bb1330","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ad2d0d","article-title":"IRGD-modified erythrocyte membrane biomimetic temozolomide nanodots for the treatment of glioblastoma","volume":"35","author":"Luo","year":"2024","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2026.115337_bb1335","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.1039\/C7NR00305F","article-title":"A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin","volume":"9","author":"Prabhu","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115337_bb1340","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejpb.2021.03.011","article-title":"Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination","volume":"163","author":"Zhang","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115337_bb1345","first-page":"147","article-title":"Non-syndrome multiple supernumerary teeth: literature review","volume":"56","author":"Yusof","year":"1990","journal-title":"J. Can. Dent. Assoc."},{"key":"10.1016\/j.jconrel.2026.115337_bb1350","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1021\/la8036499","article-title":"Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery","volume":"25","author":"Talelli","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115337_bb1355","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001812","article-title":"Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery","volume":"10","author":"Ho","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115337_bb1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127802","article-title":"Recent advances in fluorescence nanoparticles \u201cquantum dots\u201d as gene delivery system: a review","volume":"254","author":"Zahed","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1365","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/acs.jproteome.6b00747","article-title":"Cytotoxic and proinflammatory effects of metal-based nanoparticles on THP-1 monocytes characterized by combined proteomics approaches","volume":"16","author":"Tarasova","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb1370","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114829","article-title":"Nanoparticle-based immunotherapeutics: from the properties of nanocores to the differential effects of administration routes","volume":"197","author":"Perez-Potti","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1375","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejpb.2017.07.009","article-title":"Synthesis and characterization of a multifunctional gold-doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release","volume":"119","author":"Khutale","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115337_bb1380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/IJN.S177851","article-title":"Gold nanorod-encapsulated biodegradable polymeric matrix for combined photothermal and chemo-cancer therapy","volume":"14","author":"Chuang","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115337_bb1385","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400088","article-title":"Light-responsive nanoantennas integrated into nanoscale metal-organic frameworks for photothermal drug delivery","volume":"4","author":"Cedrun-Morales","year":"2024","journal-title":"Small Sci."},{"key":"10.1016\/j.jconrel.2026.115337_bb1390","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12951-021-01220-9","article-title":"A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy","volume":"20","author":"Kim","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1395","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12951-025-03529-1","article-title":"Ultrasmall nanoparticles for co-delivery of antisense oligonucleotides targeting miR-21 and miR-210 to treat glioblastoma","volume":"23","author":"Singh","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1400","first-page":"83","article-title":"Pharmacokinetics and tumor delivery of nanoparticles","author":"Yuan","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1405","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1021\/acs.analchem.9b00197","article-title":"\u201cLab-on-click\u201d detection of illicit drugs in oral fluids by MicroNIR-chemometrics","volume":"91","author":"Risoluti","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2026.115337_bb1410","doi-asserted-by":"crossref","first-page":"1601673","DOI":"10.3389\/fbioe.2025.1601673","article-title":"Innovative nanoparticle-based therapeutic strategies against glioblastoma multiform: a focus on enhanced delivery systems and efficacy","volume":"13","author":"Wang","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1415","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v16.i9.108731","article-title":"Responsive mesoporous silica nanocarriers in glioma therapy: a step forward in overcoming biological barriers","volume":"16","author":"Abdel-Maksoud","year":"2025","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1420","doi-asserted-by":"crossref","first-page":"215","DOI":"10.14791\/btrt.2022.0032","article-title":"Engineered aurotherapy for the multimodal treatment of glioblastoma","volume":"10","author":"Kim","year":"2022","journal-title":"Brain Tumor Res. Treat."},{"key":"10.1016\/j.jconrel.2026.115337_bb1425","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.7150\/thno.112204","article-title":"Inorganic and hybrid nanomaterials for NIR-II fluorescence imaging-guided therapy of Glioblastoma and perspectives","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1430","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2147\/IJN.S493565","article-title":"Application of multifunctional metal nanoparticles in the treatment of glioma","volume":"20","author":"Ren","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115337_bb1435","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12032-025-02913-z","article-title":"Superparamagnetic iron oxide nanoparticles (SPIONs) in targeting brain tumors: advances and challenges","volume":"42","author":"Maheshwari","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1440","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ibra.12198","article-title":"Nanotechnology in brain cancer treatment: the role of gold nanoparticles as therapeutic enhancers","volume":"11","author":"Tarantino","year":"2025","journal-title":"Ibrain"},{"key":"10.1016\/j.jconrel.2026.115337_bb1445","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1450","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41551-023-01142-x","article-title":"Genetically encoding multiple functionalities into extracellular vesicles for the targeted delivery of biologics to T cells","volume":"8","author":"Stranford","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115337_bb1455","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1021\/acs.chemrev.7b00663","article-title":"DNA nanotechnology-enabled drug delivery systems","volume":"119","author":"Hu","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115042","article-title":"Engineering nanoparticle toolkits for mRNA delivery","volume":"200","author":"Sun","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1465","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","article-title":"Extracellular vesicles as drug delivery systems: why and how?","volume":"159","author":"Elsharkasy","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115337_bb1470","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115337_bb1475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123456","article-title":"Colorectal cancer cell exosome and cytoplasmic membrane for homotypic delivery of therapeutic molecules","volume":"646","author":"Jarak","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115337_bb1480","article-title":"Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma","volume":"5","author":"Yang","year":"2025","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.jconrel.2026.115337_bb1485","first-page":"25","article-title":"Molecular determinants involved in the docking and uptake of tumor-derived extracellular vesicles: implications in cancer","author":"Clares-Pedrero","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115337_bb1490","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12951-024-02611-4","article-title":"Exosomes as drug delivery systems in glioma immunotherapy","volume":"22","author":"Hao","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1495","doi-asserted-by":"crossref","first-page":"13283","DOI":"10.1007\/s12274-023-5921-6","article-title":"Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety","volume":"16","author":"Zhou","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb1500","doi-asserted-by":"crossref","first-page":"1655241","DOI":"10.3389\/fphar.2025.1655241","article-title":"Advances and challenges in novel drug delivery systems for glioma therapy","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ddc4020019","article-title":"Engineered exosomes as smart drug carriers: overcoming biological barriers in CNS and cancer therapy","volume":"4","author":"Premchandani","year":"2025","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.jconrel.2026.115337_bb1510","article-title":"Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.jconrel.2026.115337_bb1515","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2015.09.059","article-title":"Liposome-based glioma targeted drug delivery enabled by stable peptide ligands","volume":"218","author":"Wei","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115337_bb1520","doi-asserted-by":"crossref","first-page":"29977","DOI":"10.1021\/acsami.6b10146","article-title":"Liposome-based systemic glioma-targeted drug delivery enabled by all-d peptides","volume":"8","author":"Ying","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115337_bb1525","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41467-025-67331-1","article-title":"mRNA vaccine developed for sequential selective organ-to-cell targeting of glioma","volume":"17","author":"Shi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb1530","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/neuonc\/noad088","article-title":"Dendritic cell vaccine trials in gliomas: untangling the lines","volume":"25","author":"Hotchkiss","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb1535","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/neuonc\/noad085","article-title":"Reply to Di Nunno et al. concerning objective response rates targets for recurrent glioblastoma clinical trials: toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma","volume":"25","author":"Ellingson","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb1540","first-page":"17","article-title":"Trends in efficacy endpoints in phase II glioblastoma trials: a regulatory science analysis (FY2020-FY2022)","author":"Watanabe","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115337_bb1545","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.neurol.2023.03.014","article-title":"Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: what happened to the evidence?","volume":"179","author":"Olivier","year":"2023","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jconrel.2026.115337_bb1550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311435","article-title":"Recurrent limitations of CAR-T therapy in gliomas: evidence from preclinical and phase I clinical studies","volume":"26","author":"Bria","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115337_bb1555","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/hemoncstem.HEMONCSTEM-D-24-00040","article-title":"A critical review of CAR-T therapies for glioblastoma: what\u2019s wrong with the current attempts?","volume":"18","author":"Belokon","year":"2025","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"10.1016\/j.jconrel.2026.115337_bb1560","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","article-title":"Brain immunology and immunotherapy in brain tumours","volume":"20","author":"Sampson","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb1565","first-page":"15","article-title":"Decoding glioblastoma through liquid biopsy: molecular insights and clinical prospects","author":"Wasiak","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115337_bb1570","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12017-021-08677-9","article-title":"Emerging technologies for non-invasive monitoring of treatment response to immunotherapy for brain tumors","volume":"24","author":"Mathios","year":"2022","journal-title":"NeuroMolecular Med."},{"issue":"219\u201335","key":"10.1016\/j.jconrel.2026.115337_bb1575","article-title":"UVB-induced tumor heterogeneity diminishes immune response in melanoma","volume":"179","author":"Wolf","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115337_bb1580","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115337_bb1585","first-page":"61","article-title":"Liquid biopsy as a diagnostic and monitoring tool in glioblastoma","author":"Tataranu","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jconrel.2026.115337_bb1590","doi-asserted-by":"crossref","first-page":"1714287","DOI":"10.3389\/fonc.2025.1714287","article-title":"Cerebrospinal fluid ctDNA as a diagnostic and prognostic tool in gliomas: a systematic review and meta-analysis","volume":"15","author":"Perez-Alfayate","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0315890","article-title":"Identification of distinct profiles of glioblastoma through the immunocapture of extracellular vesicles from patient plasma","volume":"20","author":"Manu","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115337_bb1600","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1038\/s41467-025-65681-4","article-title":"Dynamic release of extracellular particles after opening of the blood-brain barrier predicts glioblastoma susceptibility to paclitaxel","volume":"16","author":"Youngblood","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb1605","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12880-025-01906-8","article-title":"Evaluating machine learning models for post-surgery treatment response assessment in glioblastoma multiforme: a comparative study of gray level co-occurrence matrix (GLCM), curvelet, and combined radiomics features selected by multiple algorithms","volume":"25","author":"Alibabaei","year":"2025","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.jconrel.2026.115337_bb1610","first-page":"18","article-title":"Circulating tumor cells in glioblastoma","author":"Eibl","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115337_bb1615","doi-asserted-by":"crossref","first-page":"v24","DOI":"10.1093\/neuonc\/noaf201.0091","article-title":"Plasma biomarkers for non-invasive glioblastoma diagnosis: a multimarker strategy with GFAP, UCH-L1, NFL, TAU, MPO, and PMN elastase","volume":"27","author":"Decarpentrie","year":"2025","journal-title":"Neuro-Oncology."},{"key":"10.1016\/j.jconrel.2026.115337_bb1620","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/1078-0432.CCR-24-1814","article-title":"Longitudinal glioma monitoring via cerebrospinal fluid cell-free DNA","volume":"31","author":"Riviere-Cazaux","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb1625","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.annonc.2025.02.005","article-title":"ctDNA detection in cerebrospinal fluid and plasma and mutational concordance with the primary tumor in a multicenter prospective study of patients with glioma","volume":"36","author":"Cabezas-Camarero","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1630","first-page":"1064","article-title":"Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial","volume":"7","author":"Garfinkle","year":"2026","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115337_bb1635","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s42256-025-01073-z","article-title":"Self-iterative multiple-instance learning enables the prediction of CD4+ T cell immunogenic epitopes","volume":"7","author":"Shen","year":"2025","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.jconrel.2026.115337_bb1640","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s42003-025-08500-2","article-title":"HLAIIPred: cross-attention mechanism for modeling the interaction of HLA class II molecules with peptides","volume":"8","author":"Haghighatlari","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1645","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1038\/s41467-025-60461-6","article-title":"Identifying T cell antigen at the atomic level with graph convolutional network","volume":"16","author":"Que","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115337_bb1650","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41587-024-02420-y","article-title":"A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy","volume":"43","author":"Huber","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1655","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12561-019-09245-3","article-title":"Flexible Phase I-II design for partially ordered regimens with application to therapeutic cancer vaccines","volume":"12","author":"Wages","year":"2020","journal-title":"Stat. Biosci."},{"key":"10.1016\/j.jconrel.2026.115337_bb1660","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ajco.70006","article-title":"Personalized cancer vaccines in the clinical trial pipeline","volume":"22","author":"Iamukova","year":"2026","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1665","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/nox168.520","article-title":"Overcoming glioblastoma resistance to immune checkpoint blockade via RNA-loaded nanoparticles","volume":"19","author":"Sayour","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.115337_bb1670","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1158\/1078-0432.CCR-20-0472","article-title":"Intratumoral IL12 mRNA therapy promotes TH1 transformation of the tumor microenvironment","volume":"26","author":"Hewitt","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb1675","first-page":"13","article-title":"PD-1 blockade employed at the time CD8+ T cells are activated enhances their antitumor efficacy","author":"Moseman","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115337_bb1680","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251316988","article-title":"Impact of systemic anticancer therapy timing on cancer vaccine immunogenicity: a review","volume":"17","author":"Gomez-Randulfe","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1685","doi-asserted-by":"crossref","first-page":"11990","DOI":"10.1038\/srep11990","article-title":"LRP-1-mediated intracellular antibody delivery to the central nervous system","volume":"5","author":"Tian","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115337_bb1690","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/bs.apha.2026.02.005","article-title":"Brain delivery of lipid nanoparticles with shuttle peptides","volume":"105","author":"Martinez-Martinez","year":"2026","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1695","doi-asserted-by":"crossref","first-page":"12187","DOI":"10.1039\/D5NR00984G","article-title":"Tuning lipid nanocarrier mechanical properties to improve glioblastoma targeting and blood brain barrier penetration","volume":"17","author":"Robles-Fernandez","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115337_bb1700","first-page":"18","article-title":"Matrix metalloproteinase-2-responsive peptide-modified cleavable PEGylated liposomes for paclitaxel delivery","author":"Zhao","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jconrel.2026.115337_bb1705","article-title":"Transient blood-brain barrier opening by focused ultrasound enhances ferumoxytol accumulation in glioblastoma","volume":"38","author":"Saladino","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115337_bb1710","doi-asserted-by":"crossref","DOI":"10.1172\/JCI195639","article-title":"Discovery and therapeutic delivery of microRNAs targeting deregulated glioblastoma pathways inhibits tumor growth in mice","volume":"136","author":"Saha","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115337_bb1715","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2026.100296","article-title":"Multi-stimuli responsive nanoparticles: next-generation platforms for smart drug delivery","volume":"29","author":"Ahmad","year":"2026","journal-title":"OpenNano"},{"key":"10.1016\/j.jconrel.2026.115337_bb1720","article-title":"pH-responsive polymers: classification, response mode, properties and biomedical applications","volume":"523","author":"Wang","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.115337_bb1725","first-page":"2020","article-title":"Enzyme-responsive nanoparticles for anti-tumor drug delivery","volume":"8","author":"Li","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2026.115337_bb1730","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7774\/cevr.2025.14.e40","article-title":"Advancements and challenges in next-generation mRNA vaccine manufacturing systems","volume":"14","author":"Seo","year":"2025","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.jconrel.2026.115337_bb1735","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070918","article-title":"The United States Food and Drug Administration\u2019s platform technology designation to expedite the development of drugs","volume":"16","author":"Niazi","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1740","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae585","article-title":"NeoDesign: a computational tool for optimal selection of polyvalent neoantigen combinations","volume":"40","author":"Yu","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jconrel.2026.115337_bb1745","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41587-024-02306-z","article-title":"Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency","volume":"43","author":"McGee","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115337_bb1750","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ymthe.2025.10.038","article-title":"CircRNA: unlocking new frontiers in therapeutic and vaccine development","volume":"34","author":"Bahrulolum","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115337_bb1755","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114740","article-title":"Lipid nanoparticle (LNP)-mediated cytoplasmic expression of single-stranded DNA and its application in Mpox vaccine","volume":"392","author":"Zhang","year":"2026","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:24:21Z","timestamp":1793337861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":351,"alternative-id":["S0168365926007418"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115337","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA vaccines for glioblastoma: integrating multiomics and nanomedicine to overcome spatiotemporal heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115337"}}